Suppression of miR-142 expression in CD4+ T cells from patients suffering from autoimmune diseases such as SLE (19) predicts that PDE3B expression and activity may be enhanced in these cells and that this may underlie disease etiology. Here, PDE3B is linked to systemic lupus erythematosus.